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Introducing Research Initiatives into Healthcare:
What Do Doctors Think?
Lucy Wyld,1 Sian Smith,1 Nicholas J. Hawkins,2 Janet Long,3 and Robyn L. Ward1,4
Background: Current national and international policies emphasize the need to develop research initiatives
within our health care system. Institutional biobanking represents a modern, large-scale research initiative that
is reliant upon the support of several aspects of the health care organization. This research project aims to
explore doctors’ views on the concept of institutional biobanking and to gain insight into the factors which
impact the development of research initiatives within healthcare systems.
Methods: Qualitative research study using semi-structured interviews. The research was conducted across two
public teaching hospitals in Sydney, Australia where institutional biobanking was being introduced. Twenty-
five participants were interviewed, of whom 21 were medical practitioners at the specialist trainee level or
above in a specialty directly related to biobanking; four were key stakeholders responsible for the design and
implementation of the biobanking initiative.
Results: All participants strongly supported the concept of institutional biobanking. Participants highlighted the
discordance between the doctors who work to establish the biobank (the contributors) and the researchers who
use it (the consumers). Participants identified several barriers that limit the success of research initiatives in the
hospital setting including: the ‘resistance to change’ culture; the difficulties in engaging health professionals in
research initiatives; and the lack of incentives offered to doctors for their contribution. Doctors positively
valued the opportunity to advise the implementation team, and felt that the initiative could benefit from their
knowledge and expertise.
Conclusion: Successful integration of research initiatives into hospitals requires early collaboration between the
implementing team and the health care professionals to produce a plan that is sensitive to the needs of the health
professionals and tailored to the hospital setting. Research initiatives must consider incentives that encourage
doctors to adopt operational responsibility for hospital research initiatives.
Introduction
While research is essential in achieving continuoushealth improvement,1 it will not deliver improved
patient outcomes without the input of patients and clini-
cians, and the support of health care organizations.
Unfortunately, modern health care systems are under in-
creasing financial pressure, and this restricts the resources
and infrastructure available to facilitate high-quality re-
search.2 Healthcare policies and financial incentives are
one way of supporting and promoting research initiatives
in health care systems.3–6 However, it is also important to
understand the interpersonal and organizational factors
that impact on the development of research initiatives
within the hospital setting. To do so, we performed a
qualitative research study on one such research initiative,
namely the implementation of a biobanking strategy within
public hospitals.
Institutional biobanking is the organized collection of
biological materials and associated information for the
purposes of research, and these materials are collected as
part of routine health care workflows.7 It is an example of a
research innovation, the success of which requires the
support of several aspects of a health care system.8 In-
stitutional biobanking has been chosen for this study as it
represents a modern, large-scale research initiative of glo-
bal significance.9,10
The molecular revolution has driven demand for high-
quality annotated biospecimens as an essential resource in
improving our understanding of disease.11 Accepted bio-
banking models are changing in response to this demand, with
small-scale, investigator-driven, and study-specific biobanks
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being superseded by large, institutional biobanks embed-
ded in routine hospital practice.12 These changing practices
aim to improve efficiency by reducing redundancy of speci-
men collection, processing, and administration.
While the ‘institutionalization’ of biobanking has achieved
many of its goals, it brings a new set of challenges.13 Suc-
cessful integration of research initiatives into health care
systems relies upon a significant culture shift, complex system
reorganization, and the cooperation of professionals from all
areas of translational medicine.14 This qualitative research
study aims to explore these issues from the perspectives of
hospital doctors involved in biobanking and the stakeholders
responsible for the implementation of the biobanking strategy.
The key aims of the study are (1) to explore doctors’ and
stakeholders’ views on the concept of institutional biobanking,
and (2) to gain insight into the factors that impact its im-
plementation in a hospital setting.
Methods
Design and setting
The Health Science Alliance (HSA) Biobank is an insti-
tutional biobanking initiative established by a consortium of
researchers and clinicians, with financial support from their
institutions and the state government. The initiative began in
April 2012 at two public teaching hospitals in Sydney, with
the long-term goal of expansion to hospitals throughout
New South Wales (NSW), Australia. Typically, consent is
obtained by the nursing and medical staff involved in the
routine care of the patient. Tissues for biobanking are se-
lected within the pathology department, under the supervi-
sion of pathology staff. Participant tissues and data are
stored in the Lowy Biorepository, a purpose-built biobank-
ing facility adjacent to the hospital at UNSW. Biobank staff
act as honest brokers in the distribution of tissues to third
party researchers nationally.
Participants and recruitment
In January 2013, study participants were recruited from
two teaching hospitals in Sydney using purposive sampling,
to ensure differing levels of seniority and a range of spe-
cialties. Eligible participants were medical practitioners at the
specialty trainee level or above, who worked in a specialty
directly related to biobanking, including Anatomical Pathol-
ogy, Hematology, Medical or Radiation Oncology, and Sur-
gical Oncology. In order to gain a wider perspective, we also
interviewed four key stakeholders responsible for the design
and implementation of the institutional biobanking initiative.
Participants were recruited by e-mail invitation based on a list
of potential participants provided by each department head.
Ethics statement
Written informed consent was obtained from all study
participants. The research study was approved by the South
Eastern Sydney Local Health District Human Research and
Ethics Committee (12/260(LNR/12/POWH/468)).
Interview process
Semi-structured interviews were conducted, with partici-
pant data (demographics, level of seniority, professional title,
and active involvement in research) collected at the start of
each interview. A topic guide was designed to explore par-
ticipants’ views and experiences of the biobanking initiative.
Open questioning was used, followed by more targeted
questioning in response to the participants’ comments. Re-
flexive questioning was employed to ensure clarity of inter-
pretation. All interviews were conducted face-to-face, in the
participant’s office. Interviews were audio-recorded and
verbatim transcripts were checked independently by LW and
JL. Interviews continued until thematic saturation was
achieved as indicated by data redundancy (i.e., when partic-
ipants no longer raised novel themes).15
Transcript analysis
Researchers (LW and JL) independently reviewed tran-
scripts, developed codes in an iterative process, and applied
these to identify themes. Adopting iterative analysis enabled
the researchers to refine questions, develop, and challenge
assumptions and pursue emerging avenues of inquiry in later
interviews.
Analysis was informed by ‘Framework’, a method com-
prising five stages which deductively compiles questions
drawn from the aims, and inductively identifies themes
arising from the data:
1. Familiarization with data: Researchers (LW and JL)
independently read and re-read the transcripts to
identify themes.
2. Developing a coding framework: A framework of
themes and subthemes was created to code the data.
3. Indexing: The researchers independently applied the
framework to the transcripts and met to discuss any
inconsistencies.
4. Charting: All transcripts were coded using the frame-
work, and synthesized within a set of thematic matrix
charts, where each participant is assigned a row and
each subtheme a column.
5. Mapping: Similarities and differences regarding par-
ticipants’ experiences were sought.16,17
Participant responses were analyzed to look for trends or
disparities between professional specialization and seniority
levels, and between doctors and stakeholders.
Results
Sample characteristics
Thirty-one individuals were invited to participate, of whom
25 accepted (Table 1). Reasons for declining participation
included clinical commitments or annual leave at time of data
collection. Interviews lasted between 19 and 58 minutes
(mean duration of 42 minutes). Relevant participant quota-
tions are provided to support observations (Tables 2–4).
Concept of institutional biobanking
All participants appeared to support the concept of in-
stitutional biobanking strongly, with most basing this view
on its potential to facilitate research developments. Several
participants reported that institutional biobanks were an
essential research resource in response to the genetic revo-
lution, and provided specific examples in which specimens
could be used to refine genetic techniques or to help develop
targeted therapies. Many of the surgeons discussed the
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important role of biospecimen research in supporting the
move to personalized medicine. In contrast, some anatom-
ical pathologists and oncologists supported the concept of
institutional biobanking as it gave the hospital the oppor-
tunity to be actively involved in research.
Beneficiaries of institutional biobanking
Participants unanimously identified the researcher as the
primary beneficiary of biobanking (Table 2). They concep-
tualized the benefit to researchers in terms of streamlined
biospecimens accrual and increased efficiency of processing.
Some participants discussed patient benefit, but empha-
sized these benefits would be long term. The majority of
doctors thought patients would value the opportunity to
participate. Several surgeons recalled their experiences of
discussing biobanking with patients, and discussed the rarity
of patient refusal to consent.
Some senior doctors reflected broadly on the benefits that
participation in biobanking may bring to their department
and the hospital at large (Table 2). Only one doctor men-
tioned a potential benefit for hospital doctors. In contrast,
other doctors saw little benefit for themselves and felt that
this reduced their motivation to participate in the initiative.
In addition, the stakeholders were unable to describe any
ways in which the hospital doctors may benefit, albeit rec-
ognizing this as a barrier to the implementation process.
Balancing the beneficiaries with the benefactors. For many,
broaching the subject of benefit led to participants high-
lighting the issue of discordance between the doctors who
work to establish the biobank (the contributors) and the
researchers who use it (the consumers) (Table 2).
Anatomical Pathologists and Hematologists (the depart-
ments with the biggest role in specimen accrual) repeatedly
expressed disappointment with the lack of recognition re-
ceived for their individual and collective contributions to the
biobank. Many were aggrieved by the initiative’s failure to
recognize and acknowledge the level of pathology input re-
quired to create a biobanking resource. Several pathologists
were concerned that the initiative may jeopardize their current
communication with researchers and ultimately undermine the
value of their profession (Table 2). In comparison, they felt
that the existing small-scale biobanking models enabled the
pathologist more autonomy and recognition. Among patholo-
gists and surgeons, the dissatisfaction with lack of recognition
was exacerbated by the failure of researchers to appreciate the
lengthy processes of tissue preparation (Table 2).
Suggestions for how best to acknowledge contributors
included recognition as co-partners of the initiative, or being
named authors on publications resulting from the biospeci-
men research.
All but one of the stakeholders discussed this same mismatch
between the biobank contributors and consumers and felt this to
be a major barrier to engaging the doctors in the initiative.
However, while the contributors suggested ways of achieving
acknowledgement, the stakeholders took a more pragmatic
view, seeing the difficulties in acknowledging contributors as
an inevitable consequence of institutional biobanking.
Barriers to the implementation
of institutional biobanking
Many participants discussed practical transitory chal-
lenges to the implementation of the biobank, such as the
lack of a single point of contact with whom to raise issues
and the difficulty in finding consent forms and tracking
consent. Although these logistical details could impact sig-
nificantly on the success of an initiative, the focus of this
article is on the more fundamental issues affecting the im-
plementation process.
Difficulties in engaging clinicians in the implementation pro-
cess. Doctors and stakeholders were acutely aware of the
difficulties in establishing and maintaining engagement with
hospital staff regarding the biobanking initiative (Table 3).
Doctors felt that a greater effort should have been made to
engage them at all stages of the implementation process, and
that regular communication and feedback opportunities
would have created awareness within the hospital and im-
proved the participation of hospital staff (Table 3). Stake-
holders reflected on the difficulties in targeting such a
diverse group of professionals and found large-scale pre-
sentations to be the most effective means of communicating.
In contrast, most doctors favored face-to-face, individual
discussions rather than presentations and information ses-
sions. They felt that discussions offered the chance for two-
way communication between the implementing team and
the doctor, giving them a valuable opportunity to make
suggestions to the implementation team who as a result
could benefit from their knowledge and expertise.
Some doctors felt they should have been more involved in
the initiative at the early phases of design and planning.
Amongst those who held this view, it was clear that if the
desired steps were not taken in the early phase to engage
them, then they would subsequently lose all enthusiasm for
the initiative (Table 3).
Resources. All but one respondent expressed concern about
the resourcing of the biobank (Table 3), although this issue
was not raised by fellows or specialist trainees. Two main
themes emerged. First, participants recognized the long-term
nature of a biobanking strategy and its limited ability to at-
tract funding in the early years. Second, the respondents, and
in particular the surgeons, were concerned about the impact
Table 1. Characteristics of the 25 Study
Participants
Variable Number (%)
Specialty
Anatomical Pathology 5 (20)
Hematology 5 (20)
Radiation/Medical Oncology 6 (24)
Surgical Oncology 5 (20)
Stakeholder* 4 (16)
Sex
Male 17 (68)
Female 8 (32)
Position
Consultant (Staff Specialist) 13 (52)
Clinical Fellow/Specialist Trainee 9 (36)
Stakeholder* 4 (16)
Active participant in research** 12 (48)
*Stakeholder refers to individuals who are deeply engaged in the
institutional biobanking initiative, but who do not have a role within
the hospital. **Active participant in research refers to individuals
who are currently involved in conducting or supervising medical
research.
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the extra workload would have on their departments. How-
ever, all doctors interviewed felt that the initiative had made
little difference to their own clinical workload.
Responsibility. When asked to discuss the barriers that have
slowed or prevented implementation, all stakeholders and
some doctors introduced the issue of responsibility (Table 3).
They recognized the large gap between enthusiastic reception
of the initiative, and actual adoption by doctors of operational
responsibility. All participants expressed enthusiasm and
support for the concept of institutional biobanking, and all
envisaged future growth of this research tool. However, there
were mixed views of their role in developing and sustaining
this resource, with no clear differences based on specialty or
seniority. The majority viewed biobanking as a researcher’s
responsibility, since researchers benefitted from the resource.
Others felt that it should be led by enthusiasts within the
hospital (Table 3).
In the same vein, participants were asked to discuss their
views of the doctor’s role in research (Table 3). Many par-
ticipants felt passionately about this, becoming more ani-
mated during this part of the interview and more loquacious
in their answers. All doctors agreed that research should play
an integral role within teaching hospitals, although opinions
were divided as to the doctor’s role in that research. Senior
members of departments were more likely to dispute the
proposition that doctors are obliged to engage in research.
They justified this view by discussing the negative service
implications of having too many researchers within a de-
partment. Opinions regarding the role of doctors in research
were not influenced by the respondent’s own involvement in
research. Many of the doctors not active in research said they
would like to be when they had more time.
The hospital environment. Participants discussed several
barriers that the hospital environment presents to new
Table 2. Participant Views on the Beneficiaries of Biobanking
and the Need to Recognize the Benefactors
Concept Quotation
The researcher will benefit the most
from institutional biobanks
So researchers can apply to a centralized system instead of going through
multiple different channels and departments to obtain tissue (3, Anatomical
Pathology, Fellow/Specialist Trainee)
Researchers will be provided with a sustainable source of samples so they don’t
have to go around various departments seeking consents to obtain them. (17,
Medical Oncology, Fellow/Specialist Trainee)
Patients may benefit Of course patients at the end point of the research, the whole reason the research
is done. (2 Medical Oncology, Consultant)
One could be altruistic and say all patients in the future (24, Surgical Oncology,
Consultant).
The wider concept of benefit The hospital system as a whole, can be seen to be innovative and doing something
really worthwhile. (5, Anatomical Pathology, Consultant)
Ultimately it is a public library and so everyone stands to benefit. (8, Medical
Oncology, Consultant)
It is an opportunity to do something bigger than ourselves and may raise the
profile of our department. (25, Hematology, Consultant)
Patients support the concept of
biobanking
Patients clearly want to do this, they have got the disease and they want research
to fix it, they want us to learn how to prevent, diagnose and treat it better. (1,
Surgical Oncology, Consultant)
I think a lot of patients feel great, as they have been able to help someone. (14,
Hematology, Consultant)
I think people with cancer particularly see this as a good thing as they want to see
something good come of their cancer (12, Medical Oncology, Fellow/Specialist
Trainee)
The mismatch between the creators
of biobanks and those who
benefit from them.
Researchers are the winners as they can just use it without any direct negative
effects. (21, Radiation Oncology, Consultant)
There is a mismatch between the users who contribute nothing to the generation
of it but merely consume and the contributors who get nothing out of it. (23,
Anatomical Pathology, Consultant)
Ways to acknowledge the creators
of biobanks
Our contribution is not recognized and certainly not rewarded, we are providing
the tissue and the diagnoses to be effectively sold to researchers and we get
nothing for it. I would suggest academic contributions so we can say we are a
founding contributor. (20, Anatomical Pathology, Consultant)
Yes it is a great idea, but what is in it for me? As it has not been set up as a
partnership between those groups who are doing the work and therefore we are
reluctant to contribute (25, Hematology, Consultant)
Risk of not acknowledging
contributors
If our intellectual contribution is not recognized, pathologists are in danger of
being thought of as merely a tissue transit and processing facility. (5,
Anatomical Pathology, Consultant)
The table shows both the typical responses and the range of views expressed. Quotations are labeled by participant number, specialty,
and seniority.
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initiatives, including its culture of ‘resistance to change’
(Table 3). Stakeholders gave in-depth accounts of the ob-
stacles presented by the institutional nature of their hospital.
Several stakeholders reflected on the difficulty in estab-
lishing changes in modern health care systems where mul-
tiple departments and professionals are involved in each
stage of the patient journey. In contrast, only a few doctors,
mostly those with experience in implementing hospital-wide
changes, raised this issue.
Implementation strategies
Views of participants regarding strategies to better imple-
ment institutional biobanking are shown in detail in Table 4.
Champions. The most common strategy suggested by par-
ticipants, to encourage clinician involvement in biobanking,
was the establishment of departmental champions (Table 4).
Anatomical pathologists consistently reported the way their
departmental champion had driven the implementation and
Table 3. Participants’ Views on the Barriers to Implementation of the Biobank
Concept Quotation
Early engagement and active
involvement of participants
It is important to consult people at all levels to find out what works and what
doesn’t, rather than just telling them it’s going to happen. (7, Hematology,
Fellow/Specialist Trainee)
If the implementers had been more proactive in reaching out to us then we would
have been more involved and would have felt included. Now we feel
completely divorced from the whole process. (6. Surgical Oncology,
Consultant)
You need to involve people in the design, the governance and the glory that
comes with it. (19, Hematology, Consultant)
Need for resources to support
the initiative
Our department is not staffed to do research, they are staffed to purely get through
the clinical workload, and every hour spent doing research is an hour we need
to make up at the end of the day. (20, Anatomical Pathology, Consultant)
In reality it depends on resourcing; if a department is short staffed then they are
going to just get the basic clinical work done, and so if a new initiative that
comes in on top of that, people will be resentful of it. (9, Surgical Oncology,
Fellow/Specialist Trainee)
Doctors don’t want to take
responsibility for biobanking
Doctors are quite happy to listen to an idea and say yes as long as it doesn’t
involve any extra work. (6, Surgical Oncology, Consultant)
The big problem is finding doctors who will take responsibility for a certain step,
that is where you meet resistance (15, Stakeholder)
It is someone else’s responsibility
to make it happen
It should be the responsibility of the end users, the researchers. (14, Anatomical
Pathology, Consultant)
It should be the responsibility of people who want to do research. (1, Surgical
Oncology, Consultant)
I am sure we would bank 100 per cent of samples if the practice were completely
independent of us. We all said ‘‘yes, absolutely fine, bank as many samples as
you can if someone just organizes the consent for us and do the banking.’’ (24,
Surgical Oncology, Consultant)
Research is part of a doctor’s role It’s definitely the role of a doctor to do research and that is why I actively support
projects like this biobank. (6, Surgical Oncology, Consultant)
I think research should be part of every teaching hospital just like teaching should
be. Consultants should not join a teaching hospital just to sit there and do their
job, they should all have an active role in research (5 Anatomical Pathology,
Consultant)
Healthcare cannot support all
doctors doing research
In a better world, one would argue that this is part of our job. However in reality it
should not be obligatory, not everyone in the department needs to be keen on
research.(19, Hematology, Consultant)
We are not paid to do research and to be honest the running of a department is
dependent on some individuals not engaging in research. (23, Anatomical
Pathology, Consultant)
Difficulties in changing
hospital practice
Some of us are a bit wary, as this is all new. (9, Surgical Oncology, Fellow/
Specialist Trainee)
People in the hospital are not receptive to anything that changes their current way
of working. (15, Stakeholder)
You have to successfully change practice and even with such a minor change you
have to have the infrastructure to cope with it. (21, Radiation Oncology,
Consultant)
Some practices have gone on for a long time and so to try to introduce change
into those will be very hard. (24, Surgical Oncology, Consultant)
The table shows both the typical responses and the range of views expressed. Quotations are labeled by participant number, specialty,
and seniority.
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motivated colleagues. Doctors from other specialties recog-
nized the importance of champions, but could not identify
one within their department. The stakeholders also recog-
nized the theoretical value of champions and discussed the
difficulties in establishing these key individuals.
Approach. Participants were asked to reflect on the relative
merits of two common approaches in the implementation of
the biobank. First, the ‘top-down’ approach which involves
initial engagement with senior staff members and executives,
and subsequent dissemination of information and tasks to
subordinate staff. Overall, doctors saw the advantages of this
approach but felt that if the initiative was endorsed solely by
high-level staff within the hospital, it could lead to indif-
ference by those on the ground. However, several doctors
recognized that this ‘top-down approach’ may be required
for ethico-legal reasons and the purposes of formality.
In comparison, most participants favored a ‘bottom-up’
approach, where the skills and experiences of those on the
front line could be used to develop the most effective im-
plementation program.
Future of biobanks. All participants agreed that biobanking
would continue to grow, with several participants discussing the
development and expansion of international biobanks. Some
doctors discussed the possibility of moving towards an ‘‘opt-
out’’ consent process. However, in the face of this changing
environment, several Anatomical Pathologists emphasized the
need to maintain the focus on the patient. ‘‘Whatever direction
biobanking takes in the future, we need to be careful that we are
protecting the interests of the patient at every step’’ (3, Ana-
tomical Pathology, Fellow/Specialist Trainee).
Discussion
Biobanking, similar to many research initiatives, presents a
problem to implementers, as there is an inherent mismatch
between those who contribute to the generation of the resource
and the end users.22 This study provides evidence of dissat-
isfaction amongst doctors with this model, since it requires
their input and support without any tangible benefits. Despite
the enthusiasm for biobanking amongst doctors, the lack of
incentives to contribute to this initiative ultimately results in
their de-motivation and disengagement. This has been ob-
served in other studies exploring clinicians’ participation in a
range of research-related activities.23–27 To overcome this
barrier, clear incentives for doctors are needed. These may be
difficult to provide in resource-poor environments. Interest-
ingly, however, the results of this study show that doctors do
not expect financial incentives, but merely recognition for
their intellectual and practical contributions.
This study describes the challenges that originate from the
nature of the hospital environment. Study participants ac-
knowledged the ‘‘resistance to change’’ culture that exists
within well-established organizations, and the need to create a
supportive infrastructure to implement change. These chal-
lenges echo those of previous research, which document the
difficulties in achieving and sustaining change within orga-
nisations.28,29 In addition, this study highlights the importance
of champions in facilitating this implementation process.
The successful integration of research into hospitals relies
upon collaboration between researchers and clinicians. This
study highlights how many doctors would like to become
Table 4. Participants’ Views on Strategies to Help Implementation of Institutional Biobanking
and the Future of Biobanking
Concept Quotation
The value of champions (Name) continually pushed the project and was there to quell people’s concerns
and take the lead on things (5, Anatomical Pathology, Consultant)
A champion is needed who understands the day to day running of the department
and is on site to answer any questions and concerns as they present. The
champion needs to continually push the initiative to stop it from falling of the
agenda. (4, Hematology, Fellow/Specialist Trainee)
You have to have a sort of champion who is going to drive the process; they are
rare but when you get people like that, they really make the difference. (2,
Medical Oncology, Consultant)
Firstly it is a matter of targeting the right groups of people within the hospital,
general e-mail is not effective. You need to recruit people who have the
inclination to support the project and who will be involved in championing it in
their specialty, this is easier said than done (8, Stakeholder)
The need to combine different
approaches during implementation
The approach needs to be multi-faceted; you need the buy in from the top but also
the active involvement on the ground to change the culture. You need to
encourage people at all levels of the health system, from administrative staff,
nurses, and doctors to governing bodies. (1, Surgical Oncology, Consultant)
The ‘top-down’ approach is important but not on its own, as it is heavily reliant
on people disseminating the information. (19, Hematology, Consultant)
Biobanking will continue to grow It is just going to continue to expand, there is a genetic revolution going on as
well as the new era of personalized medicine and so more and more tissues will
be needed. (3, Anatomical Pathology, Consultant)
I think it should be universal; it would be ideal if it comes to the point that
everybody stepping into a medical facility knows that, unless they object, their
tissue is going to stored and used for research under the appropriate
governance. (14, Hematology, Consultant)
The table shows both the typical responses and the range of views expressed. Quotations are labeled by participant number, specialty,
and seniority.
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more involved in research, yet at present feel their contri-
butions are undervalued by both the researchers and the
stakeholders implementing the research programs. These
sentiments inevitably create a divide between the research-
ers and the doctors. This study also demonstrates how the
introduction of large-scale research initiatives, such as in-
stitutional biobanking, can risk worsening this divide. As
small collaborations between researchers and doctors are
superseded by large-scale initiatives, doctors may fear a loss
of established links with colleagues in research. To over-
come these issues, doctors in this study felt that the skills
and experiences of clinicians should be used to develop the
most effective implementation program. The importance of
establishing and maintaining communication links between
the implementing team and the health care professionals
during the implementation of new research initiatives was
stressed in order to prevent disengagement.
Strengths and limitations
The qualitative design is strength of this exploratory study,
as in an area of scant research, it allowed unanticipated find-
ings to emerge. While the generalizability of findings is limited
in a study of this size conducted at only two sites, it is re-
assuring that those results broadly reflect the existing literature.
Conclusions
International policies recognize the growing importance
of research innovation in modern health care systems. Also
the qualitative literature clearly indicates that patients see
biobanking and other research initiatives as an opportu-
nity to help others and contribute to medical research.18–21
However in practice, the health care environment presents a
significant challenge to incoming research initiatives. Our
findings show that successful integration of research initia-
tives into hospitals relies upon early collaboration between
the implementing team and the health care professional.
This early collaborative approach would enable the im-
plementation of a strategy that is both sensitive to the needs
of health care professionals and tailored to the hospital
setting. This study suggests that initiatives must acknowl-
edge the contributions of doctors in order to encourage them
to adopt operational responsibility for hospital research. It is
clear that enthusiasm for research exists among doctors, but
this must be acknowledged and directed to enable the suc-
cessful integration of research activities within health care
systems to be achieved. However, the question remains as to
who should be ultimately responsible for conducting re-
search within health care systems.
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